Testimonial: Cystic Fibrosis Patient Eliminates Pseudomonas Aeruginosa with CDS Protocol

Laboratory results - Pseudomonas Aeruginosa clearance

Laboratory results - Pseudomonas Aeruginosa clearance

Laboratory results - Pseudomonas Aeruginosa clearance

This is a testimonial from a 48-year-old woman named Sol who lives with Congenital Cystic Fibrosis, a chronic condition that affects her lungs, pancreas, and ears. Sol has been under pneumology care since approximately age 5.

Background

Sol currently breathes with only 32% lung capacity, as Cystic Fibrosis is a progressive chronic disease. In May 2023, she was diagnosed with Pseudomonas Aeruginosa, a bacterial infection that is extremely difficult to eradicate and considered life-threatening in cystic fibrosis patients.

Over three years, Sol was hospitalized twice for 15 days each time, receiving extremely strong intravenous antibiotics. Despite aggressive treatment, the medical team could not eliminate the bacteria. Upon discharge, she was prescribed additional antibiotics to continue at home, but the infection persisted.

In May 2025, after her second hospitalization, her physician told her that the bacteria would never be completely eliminated.

Experience

In June 2025, Sol made a significant decision: she discontinued all conventional medication and began taking CDS daily without interruption, following Protocol T and sometimes Protocol C, along with one enema per day. She learned to prepare and administer the enemas herself, ensuring she never ran out of product.

During August 2025, Sol experienced a difficult transition period as her body adapted to replacing 43 years of conventional medication with a new daily regimen. At her most severe point, she administered up to 3 enemas per day due to high fever. She reported that each enema provided tremendous relief.

Throughout this period, Sol studied extensively — watching videos about CDS recovery and the elimination of Pseudomonas Aeruginosa. She maintained strict consistency, setting alarms to ensure she never missed a dose, even during sleep.

Protocol Applied

• CDS daily administration (Protocol T and Protocol C)
• Enemas: 1-3 per day during acute phases
• Duration: June 2025 to present (over 8 months continuous)
• Discontinued: All conventional medications including ibuprofen and aspirin

Results

In December 2025, after 6 months of uninterrupted CDS use, Sol underwent laboratory studies. She informed her physician about her CDS protocol and discontinuation of conventional medication. The results arrived on February 10th, 2026, confirming that Pseudomonas Aeruginosa was no longer detectable in her system.

As of the date of this testimonial, Sol continues Protocol C plus enemas. In over 8 months, she has not taken a single dose of ibuprofen, aspirin, or any other conventional medication. Her physicians and family were unable to believe the results initially.

Sol currently maintains Protocol C with enemas and reports sustained improvement.

Why This Case Matters

This case is significant because Pseudomonas Aeruginosa is widely considered incurable in cystic fibrosis patients. Sol's experience demonstrates that consistent use of CDS protocols, combined with enemas, may offer a path toward bacterial clearance where conventional medicine has failed. Her case also highlights the importance of patient agency — learning to self-manage treatment and maintaining unwavering consistency.

Source

Personal testimonial received via Telegram. Patient provided laboratory results and daily medication log. Date: February 2026.